Bertelsen AS - Search Results

1

Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment.

Christiansen RL, Dysager L, Hansen CR, Jensen HR, Schytte T, Nyborg CJ, Bertelsen AS, Agergaard SN, Mahmood F, Hansen S, Hansen O, Brink C, Bernchou U. Christiansen RL, et al. Among authors: bertelsen as. Radiother Oncol. 2022 Feb;167:165-171. doi: 10.1016/j.radonc.2021.12.013. Epub 2021 Dec 16. Radiother Oncol. 2022. PMID: 34923034 Free article.

2

Set-up errors in patients undergoing image guided radiation treatment. Relationship to body mass index and weight loss.

Johansen J, Bertelsen A, Hansen CR, Westberg J, Hansen O, Brink C. Johansen J, et al. Acta Oncol. 2008;47(7):1454-8. doi: 10.1080/02841860802256517. Acta Oncol. 2008. PMID: 18663647

3

Cone beam CT evaluation of patient set-up accuracy as a QA tool.

Nielsen M, Bertelsen A, Westberg J, Jensen HR, Brink C. Nielsen M, et al. Acta Oncol. 2009;48(2):271-6. doi: 10.1080/02841860802245155. Acta Oncol. 2009. PMID: 18759138

4

The representitativeness of patient position during the first treatment fractions.

Bertelsen A, Nielsen M, Westberg J, Jensen HR, Brink C. Bertelsen A, et al. Acta Oncol. 2009;48(2):259-66. doi: 10.1080/02841860802251542. Acta Oncol. 2009. PMID: 18850335

5

Reduction of Cone-Beam CT scan time without compromising the accuracy of the image registration in IGRT.

Westberg J, Jensen HR, Bertelsen A, Brink C. Westberg J, et al. Acta Oncol. 2010;49(2):225-9. doi: 10.3109/02841860903386408. Acta Oncol. 2010. PMID: 20100157

6

Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.

Bertelsen A, Hansen CR, Johansen J, Brink C. Bertelsen A, et al. Radiother Oncol. 2010 May;95(2):142-8. doi: 10.1016/j.radonc.2010.01.011. Epub 2010 Feb 24. Radiother Oncol. 2010. PMID: 20188427

7

Radiation dose response of normal lung assessed by Cone Beam CT - a potential tool for biologically adaptive radiation therapy.

Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Bertelsen A, et al. Radiother Oncol. 2011 Sep;100(3):351-5. doi: 10.1016/j.radonc.2011.08.012. Epub 2011 Sep 6. Radiother Oncol. 2011. PMID: 21903286

8

Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate.

Bertelsen A, Lorenzen EL, Brink C. Bertelsen A, et al. Med Phys. 2011 Aug;38(8):4802-10. doi: 10.1118/1.3615621. Med Phys. 2011. PMID: 21928653

9

Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning study.

Bertelsen A, Hansen O, Brink C. Bertelsen A, et al. Acta Oncol. 2012 Jul;51(6):752-8. doi: 10.3109/0284186X.2011.648341. Epub 2012 Jan 17. Acta Oncol. 2012. PMID: 22248064

10

Time evolution of regional CT density changes in normal lung after IMRT for NSCLC.

Bernchou U, Schytte T, Bertelsen A, Bentzen SM, Hansen O, Brink C. Bernchou U, et al. Radiother Oncol. 2013 Oct;109(1):89-94. doi: 10.1016/j.radonc.2013.08.041. Epub 2013 Sep 20. Radiother Oncol. 2013. PMID: 24060177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters